Moreover, PPAPs were recently described as selective agents in highly resistant neuroblastoma entities [40–43], exerting a pleiotropic effect that involves the downregulation of transcription factors which may interact with viral promoters like Myc, Myb and Stat1/3 [44]. The gene discussed is STAT1; the disease is neuroblastoma.